美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AI醫療

628.26

-1.3457-0.21%

漲家數：2

跌家數：2

平家數：- -

市盈率：- -

高：638.39

開：630.08

低：627.23

收：629.61

成交量：1,377.67萬

成交額：3.18億

市值：199.04億

流通市值：154.74億

資料載入中...

Tempus AI啓動宏大計劃，構建全球最大多模態全基因組數據集，助推AI醫療創新變革

Tempus AI獲Arpa-H最高950萬美元資助，率先在心臟病學領域部署自主AI系統

CRISPR療法可降低「壞膽固醇」和甘油三酯

Beam Therapeutics在歐洲呼吸學會2026年大會上公布Beam-302治療α-1抗胰蛋白酶缺乏症1/2期臨床試驗最新數據

Tempus AI（TEM）續跌1.69% 木頭姐減持超25萬股股份

Piper Sandler上調Tempus AI評級至「增持」，目標價從56美元大幅提升至76美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK4611/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI醫療","latestPrice":628.2648,"timestamp":1789156799999,"preClose":629.6105,"halted":0,"volume":13776673,"delay":0,"changeRate":-0.002137,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-1.345703,"latestTime":"09-11 16:00:00 EDT","open":630.0837,"high":638.3864,"low":627.2322,"amount":317931521.23481,"amplitude":0.017716,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.739347,"peRate":-15.089385,"turnoverRate":0.016758,"increases":2,"decrements":2,"flats":0,"marketCap":19904441344,"floatMarketCap":15473712256},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":638.3864,"amplitude":0.017716,"preClose":629.6105,"low":627.2322,"pbRate":"4.739347","latestPrice":628.2648,"volume":13776673,"delay":0,"open":630.0837,"prevYearClose":658.3995,"prevWeekClose":700.621,"prevMonthClose":691.9381,"prevQuarterClose":681.0329,"fiveDayClose":698.548,"twentyDayClose":625.3489,"sixtyDayClose":615.9527,"secType":"PLATE","market":"US","turnoverRate":0.016758,"peRate":-15.089385,"marketCap":19904441344,"floatMarketCap":15473712256,"timestamp":1789156799999,"nameCN":"AI醫療"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":2,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1149868878","title":"Tempus AI啓動宏大計劃，構建全球最大多模態全基因組數據集，助推AI醫療創新變革","url":"https://stock-news.laohu8.com/highlight/detail?id=1149868878","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149868878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 20:31","pubTimestamp":1789129895,"startTime":"0","endTime":"0","summary":"Tempus AI近日正式宣布，将全力打造全球规模最为庞大的多模态全基因组数据集，这一举措被视为人工智能与医疗健康深度融合的重要里程碑。通过汇聚海量全基因组序列及其关联的临床表型数据，Tempus AI致力于为科研人员和临床医生搭建一个更为坚实、可靠的数据基础设施。业内观察人士指出，这项计划的实施不仅将巩固Tempus AI在AI医疗赛道上的领先地位，更可能重塑整个行业的未来格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","HEAL","TEMT","BK4611","TEMC","ARKG","LU1861559042.SGD","BK4613","LU1861558580.USD","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134558497","title":"Tempus AI獲Arpa-H最高950萬美元資助，率先在心臟病學領域部署自主AI系統","url":"https://stock-news.laohu8.com/highlight/detail?id=1134558497","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134558497?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 04:02","pubTimestamp":1788984159,"startTime":"0","endTime":"0","summary":"Tempus AI成功获得来自美国高级卫生研究计划局（Arpa-H）的“倡导者”项目资助，金额最高可达950万美元。这笔资金将专门用于推动其在心脏病学领域部署首款完全自主运行的人工智能系统。\n这一里程碑式的进展意味着，Tempus AI正站在将自主AI技术引入心血管诊疗的最前沿。借助这笔关键资金，该公司计划加速其创新解决方案的临床落地，有望彻底革新心脏病的检测、诊断与管理方式。\n获得Arpa-H的认可，不仅凸显了Tempus AI在医疗AI赛道上的技术领导力，也为未来更广泛、更深入的自动化临床决策支持系统铺平了道路。这笔专项拨款将为其在心脏病学这一关键领域的深度应用提供强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","TEM","TEMC","LU1861559042.SGD","BK4121","BK4613","LU1861558580.USD","TEMT","HEAL","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666308786","title":"CRISPR療法可降低「壞膽固醇」和甘油三酯","url":"https://stock-news.laohu8.com/highlight/detail?id=2666308786","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666308786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 07:20","pubTimestamp":1788909654,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SYNB","BK4556","BK4139","BK4585","BK4588","LU1861559042.SGD","CRSP","ARKG","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133255075","title":"Beam Therapeutics在歐洲呼吸學會2026年大會上公布Beam-302治療α-1抗胰蛋白酶缺乏症1/2期臨床試驗最新數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1133255075","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133255075?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861674,"startTime":"0","endTime":"0","summary":"Beam Therapeutics于欧洲呼吸学会2026年大会上，公布了Beam-302在α-1抗胰蛋白酶缺乏症治疗领域1/2期临床试验的最新临床数据。在大会现场，Beam Therapeutics的研发团队详细阐述了受试者的生物标志物变化、肺功能指标改善趋势以及药物耐受性情况。公司方面表示，这些更新数据进一步验证了Beam-302的潜在疾病修饰作用，并支持其后续临床开发路径的推进。业内分析人士指出，这一进展不仅关乎Beam药业自身管线价值的重估，也可能对AATD现有标准治疗格局构成远期挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4556","LU1861558580.USD","BK4139","LU1861559042.SGD","BK4585","BEAM","BK4611","BK4535","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813965","title":"Tempus AI（TEM）續跌1.69% 木頭姐減持超25萬股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813965","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813965?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 18:16","pubTimestamp":1788344189,"startTime":"0","endTime":"0","summary":"金吾财讯 | Tempus AI（TEM）盘前续跌1.69%，最新报61.2美元。消息面上，木头姐公开最新持仓，于美东时间9月1日减持Tempus AI股份超25万股，为当日卖出规模最大标的。市场分析指，Tempus AI作为AI驱动的精准医疗数据平台，近期股价震荡，ARK此次减持规模较大，或反映其在市场回调环境下的仓位风险管理，抑或是资金重新配置至更具成长弹性标的的需要。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/Y2U1MTljZjZkNTgxMTYyODU5MDU0MTEzOA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2U1MTljZjZkNTgxMTYyODU5MDU0MTEzOA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305612","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","TEMT","LU1861558580.USD","LU1861559042.SGD","BK4611","TEMC","BK4121","ARKK","BK4585","BK4613","HEAL","BK4544","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157125118","title":"Piper Sandler上調Tempus AI評級至「增持」，目標價從56美元大幅提升至76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157125118","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157125118?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:34","pubTimestamp":1788248092,"startTime":"0","endTime":"0","summary":"Piper Sandler宣布，将Tempus AI的股票评级从“中性”上调至“增持”，同时将其目标股价由56美元提升至76美元。这一调整反映出市场对该公司未来增长前景的乐观预期，也彰显了这家医疗人工智能公司持续向好的发展态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","HEAL","LU1861559042.SGD","TEM","TEMC","BK4613","ARKG","LU1861558580.USD","TEMT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}